These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2990057)

  • 1. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].
    Goudard M; Buffard Y; Ferrari H; Regli P
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):680-3. PubMed ID: 3534767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidermatophytic activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal activity of the allylamine derivative terbinafine in vitro.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1365-8. PubMed ID: 3674847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies with R 51,211 (itraconazole).
    Espinel-Ingroff A; Shadomy S; Gebhart RJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycotic susceptibility testing of mould-fungi with allylamines by disk diffusion.
    Venugopal PV; Venugopal TV
    Indian J Med Sci; 1995 May; 49(5):109-13. PubMed ID: 8772831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.
    Shadomy S; White SC; Yu HP; Dismukes WE
    J Infect Dis; 1985 Dec; 152(6):1249-56. PubMed ID: 3905985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
    Shadomy S; Espinel-Ingroff A; Kerkering TM
    Sabouraudia; 1984; 22(1):7-15. PubMed ID: 6322364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro antifungal spectrum of itraconazole.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():7-13. PubMed ID: 2561189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of terbinafine against serious fungal pathogens.
    Ryder NS
    Mycoses; 1999; 42 Suppl 2():115-9. PubMed ID: 10865917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of clotrimazole (Bay b 5097).
    Shadomy S
    Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disk diffusion susceptibility testing of dermatophytes with allylamines.
    Venugopal PV; Venugopal TV
    Int J Dermatol; 1994 Oct; 33(10):730-2. PubMed ID: 8002146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between two culture media for in vitro evaluation of antifungal susceptibility of the Sporothrix schenckii complex.
    Stopiglia CD; Marchese DP; Heidrich D; Sorrentino JM; Vieira FJ; Scroferneker ML
    An Bras Dermatol; 2012; 87(4):561-5. PubMed ID: 22892769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Med Res; 1994 Feb; 99():71-3. PubMed ID: 8005641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].
    Meinerz AR; Nascente Pda S; Schuch LF; Cleff MB; Santin R; Brum Cda S; Nobre Mde O; Meireles MC; Mello JR
    Rev Soc Bras Med Trop; 2007; 40(1):60-2. PubMed ID: 17486256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.